CLINICAL SIGNIFICANCE OF ANTI-IFN-α ANTIBODY TITRES DURING INTERFERON THERAPY
- 1 September 1987
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 330 (8559) , 635-636
- https://doi.org/10.1016/s0140-6736(87)93034-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injectionCancer, 1987
- Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)The American Journal of Medicine, 1986
- Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.Journal of Clinical Oncology, 1985
- A radioimmunologic technique to screen for antibodies to α-2 interferonJournal of Immunological Methods, 1984
- TREATMENT OF HAIRY-CELL LEUKAEMIA WITH RECOMBINANT HUMAN α2-INTERFERONThe Lancet, 1984
- ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTSThe Lancet, 1983
- PATIENT WITH CIRCULATING ANTIBODIES TO α-INTERFERONThe Lancet, 1981
- Interferon-neutralizing antibodies in a patient treated with human fibroblast interferonNature, 1981